Neurology

The Pharmacy Times® Neurology resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?

FDA Approves Flortaucipir F18 For Patients Being Evaluated for Alzheimer Disease

Officials from the FDA have approved flortaucipir F18 (Tauvid, Eli Lilly) for intravenous injection as the first drug used to help image a distinctive characteristic of Alzheimer disease in the brain called tau pathology.

Lasmiditan For the Acute Treatment of Migraine: An Opportunity For Pharmacists

Despite triptan availability as a migraine-specific rescue, the global burden of migraine morbidity remains high.

FDA Approves Oral Therapy for Pediatric Patients With Neurogenic Detrusor Overactivity

The FDA approval of solifenacin succinate marks the first for the treatment of young pediatric patients with NDO.

New Sublingual Film for Treatment of Parkinson Disease Granted FDA Approval

Officials with the FDA have approved apomorphine hydrochloride sublingual film (APL-130277) for the acute, intermittent treatment of OFF episodes in patients with Parkinson disease.

New Research Shows Mindfulness Training May Help Patients with Multiple Sclerosis

According to the study authors, patients with MS who underwent the 4-week mindfulness training not only showed greater improvement in processing speed and regulating negative emotions than those who did not participate in any training, but they also improved compared with those who tried adaptive cognitive training (ACT).

Pharmacists Can Help Patients Relieve Migraines

These accessible health care professionals are in a pivotal position to guide those who suffer from this neurological disorder to self-treatment or refer more serious cases to physicians.

Lipid Metabolism Contributes to Intellectual Disability

This new study showed for the first time that an enzyme, known as fatty acid synthase (FASN), specifically may be responsible for causing cognitive deficits.

FDA Approves Opicapone as Add-On Treatment for Patients with Parkinson Disease

Individuals with the progressive condition often struggle to control their motor fluctuations.

New Technology Uses Optical Imaging to Map Out Tumors in the Body

Purdue University researchers have created technology that uses optical imaging to better help surgeons map out tumors in the body and understand how certain diseases affect activity in the brain.

Study: Sets of Proteins That Regulate Glucose Metabolism Strongly Associated With Alzheimer Disease

The study involved measuring the levels and analyzing the expression patterns of more than 3000 proteins in a large number of brain and cerebrospinal fluid samples collected at multiple research centers across the United States.

Selumetinib Approved by FDA for Pediatric Patients With NF1 PN

The kinase inhibitor selumetinib was approved for the treatment of pediatric patients aged 2 years and older with neurofibromatosis type 1 who have symptomatic, inoperable plexiform neurofibromas.

First Intravenous Treatment for Migraine Prevention Now Commercially Available

Eptinezumab-jjmr, the first and only intravenous treatment for migraine prevention, is now commercially available in the United States.

The Pharmacy Times® Neurology resource center provides a home for all of the latest clinical information that both neurologists and pharmacists that work within the field could find valuable. With articles covering updates from the robust pipeline of novel neurological therapies, and the newest data from all phases of clinical trials and studies in the space, it also serves as a hub of coverage from ongoing conferences and annual meetings of neurological associations.